Recent Finacing
Recent Raise
AATec Medical develops a recombinant alpha-1 antitrypsin multi-product platform and is advancing inhaled candidate ATL-105 toward proof-of-concept respiratory clinical trials, with pipeline indications including transplant and AAT deficiency.
Focus Areas
Total Raised
Funding round